Toll Brothers, Inc. TOL will release its second-quarter earnings results after the closing bell on Tuesday, May 20.

image for news How To Earn $500 A Month From Toll Brothers Stock Ahead Of Q2 Earnings

VAN BUREN TOWNSHIP, Mich. , May 19, 2025 /PRNewswire/ -- Visteon Corporation (NASDAQ: VC) announced today that it is scheduled to participate in the following upcoming investor events in the second quarter of 2025: BNP 3rd Annual Global EV & Mobility Conference, Hong Kong – May 19, 2025 Wells Fargo 2025 Industrials & Materials Conference, Chicago, IL – June 10, 2025 Deutsche Bank Global Auto Industry Conference, New York City, NY – June 12, 2025 Please note that event participation and specific dates are subject to change.

image for news Visteon Announces Participation in Upcoming Second Quarter 2025 Investor Conferences

Transcat, Inc. TRNS will release its fourth-quarter financial results after the closing bell on Monday, May 19.

image for news Transcat Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

2 Airline Stocks Enjoying Upgrades Today — Positive

AAL  DAL  JBLU  LUV  UAL   Schaeffers Research — May 19, 2025

Airline stocks United Airlines Holdings Inc (NASDAQ:UAL) and Delta Air Lines Inc (NYSE:DAL) are both brushing off broad market weakness today.

image for news 2 Airline Stocks Enjoying Upgrades Today

Gogo Q1 Earnings: The Market Finally Caught On — Positive

GOGO   Seeking Alpha — May 19, 2025

I reiterate my strong buy on Gogo Inc. after Q1 2025, as the Satcom merger exceeded expectations and drove significant cost synergies. Gogo's unique position in light inflight connectivity and low market penetration offer substantial growth, especially with accelerating private jet demand among younger buyers. The Satcom merger expands Gogo's network, boosts revenue potential, and delivers $25-30 million in run-rate cost savings, improving margins and investor value.

image for news Gogo Q1 Earnings: The Market Finally Caught On

Wall Street Analysts Look Bullish on SharkNinja, Inc. (SN): Should You Buy? — Positive

SN   Zacks Investment Research — May 19, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Wall Street Analysts Look Bullish on SharkNinja, Inc. (SN): Should You Buy?

Is It Worth Investing in Lam Research (LRCX) Based on Wall Street's Bullish Views? — Positive

LRCX   Zacks Investment Research — May 19, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Is It Worth Investing in Lam Research (LRCX) Based on Wall Street's Bullish Views?

ACAD Stock Soars as US Court Rules in Favor of Key Nuplazid Patent — Positive

ACAD   Zacks Investment Research — May 19, 2025

Acadia stock jumps 27% after winning a key patent case for Nuplazid, which will protect the drug's U.S. sales from generic erosion till 2038.

image for news ACAD Stock Soars as US Court Rules in Favor of Key Nuplazid Patent

BJ's Wholesale Q1 Earnings Coming Up: What Investors Need to Know — Neutral

BJ   Zacks Investment Research — May 19, 2025

BJ's Wholesale Club Holdings, Inc. BJ is likely to register an increase in the top line when it reports first-quarter fiscal 2025 results on May 22, before the opening bell. The Zacks Consensus Estimate for revenues is pegged at $5.18 billion, which indicates an increase of 5.2% from the prior-year reported figure.

image for news BJ's Wholesale Q1 Earnings Coming Up: What Investors Need to Know

Top Sin Stocks With Strong Upside Potential to Purchase in 2025 — Positive

BYD  DEO  MGM  PM  TAP   Zacks Investment Research — May 19, 2025

Sin stocks stir debate, but their steady returns, strong margins and recession resistance make them smart, long-term plays for performance-focused investors.

image for news Top Sin Stocks With Strong Upside Potential to Purchase in 2025

Sprouts Farmers (SFM) Just Flashed Golden Cross Signal: Do You Buy? — Positive

SFM   Zacks Investment Research — May 19, 2025

From a technical perspective, Sprouts Farmers (SFM) is looking like an interesting pick, as it just reached a key level of support. SFM recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

image for news Sprouts Farmers (SFM) Just Flashed Golden Cross Signal: Do You Buy?

Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction.

image for news Pharma giant Regeneron to buy 23andMe and its customers' data for $256M

Cramer's Mad Dash: UnitedHealth — Neutral

UNH   CNBC Television — May 19, 2025

Jim Cramer breaks down why he's keeping an eye on shares of UNH.

image for news Cramer's Mad Dash: UnitedHealth

LOS ANGELES , May 19, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 18, 2024 and October 16, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 11, 2025.

image for news ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Cramer's Stop Trading: Regeneron — Neutral

REGN   CNBC Television — May 19, 2025

Jim Camer breaks down why he's keeping an eye on shares of Regeneron.

image for news Cramer's Stop Trading: Regeneron

Novavax Stock Soars on FDA Approval for COVID Vaccine — Positive

NVAX   Schaeffers Research — May 19, 2025

Biotech stock Novavax Inc (NASDAQ:NVAX) is skyrocketing today, up 26% at $8.48 at last glance, after the U.S. Food & Drug Administration (FDA) approved the company's COVID-19 vaccine.

image for news Novavax Stock Soars on FDA Approval for COVID Vaccine

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Krispy Kreme, Inc. (DNUT) Investors To Inquire About Securities Fraud Class Action.

image for news Law Offices of Frank R. Cruz Encourages Krispy Kreme, Inc. (DNUT) Investors To Inquire About Securities Fraud Class Action

This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Most of the dividend announcements in the first half of the month were very modest, with Cardinal Health announcing a 1% boost to extend its streak to 29 years. Eight more dividend growth companies are poised to announce annual increases in the latter half of May, with popular home improvement retailer Lowe's likely to announce a 3–4% boost.

image for news Lowe's Among 8 Companies To Announce Dividend Increases In Second Half Of May

LOS ANGELES , May 19, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Compass Diversified ("Compass" or "the Company") (NYSE: CODI) for violations of the securities laws. INVESTIGATION DETAILS: According to the Company, its investigation "has preliminarily identified irregularities in Lugano's non-CODI financing, accounting, and inventory practices," adding that, "Effective May 7, 2025, Lugano's founder and CEO, Moti Ferder, resigned from all of his positions at Lugano and will not receive any severance compensation.

image for news Compass Diversified Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CODI

Arch Capital Trades Above 50-Day SMA: Time to Hold ACGL Stock? — Positive

ACGL   Zacks Investment Research — May 19, 2025

ACGL is poised to gain from new business opportunities, increased exposures, a better renewal rate environment and effective capital deployment.

image for news Arch Capital Trades Above 50-Day SMA: Time to Hold ACGL Stock?